Wei-Chiang chen
Associate Director Sanofi
Wei-Chiang Chen is Associate Director at Sanofi, where he focuses on advancing gene therapy within the Genomic Medicine Unit. He leads programs centered on RNA- and DNA-based therapeutics, developing delivery systems to enable precise gene editing in patients. His work integrates innovative delivery technologies with genomic medicine approaches to drive therapeutic outcomes. Chen plays a key role in translating gene editing and gene therapy strategies into clinical applications targeting a range of diseases.
Seminars
Tuesday 29th September 2026
Panel Discussion: Advancing Scalable Gene Editing Manufacturing & CDMO Collaboration to Preserve Product Quality & Reduce Timelines
11:30 am
- Streamlining manufacturing and analytical collaboration to preserve product purity, potency, and consistency throughout scale-up
- Optimizing CDMO partnerships and tech transfer strategies to reduce development delays and manufacturing inefficiencies
- Exploring flexible guide RNA manufacturing approaches to support scalable production across diverse rare disease populations
